FRONTLINE COMBO SPOT ON DOG M
Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
Patient Information leaflet
(PIL)
21-08-2013
Summary of Product characteristics
(SPC)
21-08-2013
Available from:
MERIAL SAS
Pharmaceutical form:
Spot-on solution
Therapeutic area:
Authorization date:
2011-05-15
Patient Information leaflet
Frontline Combo Spot on Dog M PIL May2011 MERIAL
eu-fro-pld-medium-feb11-pil-p.doc
1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
FRONTLINE COMBO SPOT-ON DOG M
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 1.34 ml contains:
Fipronil ................................................................................................................... 134.00 mg
(S)-methoprene ....................................................................................................... 120.60 mg
Butylhydroxyanisole (E320) ........................................................................................ 0.27 mg
Butylhydroxytoluene (E321) ........................................................................................ 0.13 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution
Clear amber solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing 10-to-20 kg bodyweight:
- To be used against infestations with fleas, alone or in association with ticks and/or biting lice.
- Treatment of flea infestations (_Ctenocephalides_ spp.). . Insecticidal efficacy against new
infestations with adult fleas persists for 8 weeks. Prevention of the multiplication of fleas by inhibiting
of the development of eggs (ovicidal activity) and larvae and pupae (larvicidal activity) originating from
eggs laid by adult fleas for eight weeks after application.
- Treatment of tick infestations (_Ixodes_ _ricinus_, _Dermacentor_ _variabilis, Dermacentor reticulatus_,
_Rhipicephalus_ _sanguineus_). The product has a persistent acaricidal efficacy for up to 4 weeks
against ticks.
-
Read the complete document
Summary of Product characteristics
Frontline Combo Spot on Dog M
eu-frontline-combo-dog-m-201208-pi-p
1
SUMMARY OF PRODUCT CHARACTERISTICS
Frontline Combo Spot on Dog M
eu-frontline-combo-dog-m-201208-pi-p
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
FRONTLINE COMBO SPOT-ON DOG M
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 1.34 ml contains:
Fipronil ................................................................................................................... 134.00 mg
(S)-methoprene ....................................................................................................... 120.60 mg
Butylhydroxyanisole (E320) ........................................................................................ 0.27 mg
Butylhydroxytoluene (E321) ........................................................................................ 0.13 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution
Clear amber solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing 10-to-20 kg bodyweight:
- To be used against infestations with fleas, alone or in association with ticks and/or biting lice.
- Treatment of flea infestations (_Ctenocephalides_ spp.). Insecticidal efficacy against new
infestations with adult fleas persists for 8 weeks. Prevention of the multiplication of fleas by inhibiting
of the development of eggs (ovicidal activity) and larvae and pupae (larvicidal activity) originating from
eggs laid by adult fleas for eight weeks after application.
- Treatment of tick infestations (_Ixodes_ _ricinus_, _Dermacentor_ _variabilis, Dermacentor reticulatus_,
_Rhipicephalus_ _sanguineus_). The product has
Read the complete document
